SERTOLI-LEYDIG CELL TUMOR

Clinical trials for SERTOLI-LEYDIG CELL TUMOR explained in plain language.

Never miss a new study

Get alerted when new SERTOLI-LEYDIG CELL TUMOR trials appear

Sign up with your email to follow new studies for SERTOLI-LEYDIG CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immunotherapy hope for rare cancers: new trial targets tumors ignored by big pharma

Disease control Recruiting now

This study tests the drug nivolumab in people with rare advanced cancers that have a specific marker (PD-L1). Participants must have tried standard treatments without success. The goal is to see if the drug can shrink or control tumors for at least a short time, offering a new op…

Matched conditions: SERTOLI-LEYDIG CELL TUMOR

Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

SERTOLI-LEYDIG CELL TUMOR

Get alerted when new SERTOLI-LEYDIG CELL TUMOR trials appear

Immunotherapy hope for rare cancers: new trial targets tumors ignored by big pharma